Back to User profile » Dr Maria Buti
Papers published by Dr Maria Buti:
Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
Perales C, Chen Q, Soria ME, Gregori J, Garcia-Cehic D, Nieto-Aponte L, Castells L, Imaz A, Llorens-Revull M, Domingo E, Buti M, Esteban JI, Rodriguez-Frias F, Quer J
Infection and Drug Resistance 2018, 11:2207-2210
Published Date: 8 November 2018
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Sarrazin C, Castelli F, Andreone P, Buti M, Colombo M, Pol S, Calinas F, Puoti M, Olveira A, Shiffman M, Stern JO, Kukolj G, Roehrle M, Aslanyan S, Deng Q, Vinisko R, Mensa FJ, Nelson DR
Clinical and Experimental Gastroenterology 2016, 9:351-363
Published Date: 24 November 2016